# Enveric Biosciences, Inc.: Form 8-K/A, filed Oct 6, 2022

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K/A
- Filed: 2022-10-06
- Accepted by EDGAR: Oct 6, 2022, 17:00 ET
- Period: 2022-09-20
- Accession: 0001493152-22-027827
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315222027827/form8-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315222027827/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315222027827/form8-ka.htm

Filed Oct 6, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-027827. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
